Are another 5 years of adjuvant aromatase inhibitor therapy needed? by Mo QG, Li DQ, Zhong JH, Wei CY

Subjects: Get full text

A case series of aggressive angiomyxoma: Using morphologic type and hormonal modification to tailor treatment by Joni Kooy, Vanessa Carlson, Lana Šačiragić, Summit Sawhney, Gregg Nelson

Subjects: Get full text

Assessing Predictors of Tamoxifen Nonadherence in Patients with Early Breast Cancer by Montagna E, Zagami P, Masiero M, Mazzocco K, Pravettoni G, Munzone E

Subjects: Get full text

Both “Vitamin L for Life” and “One Milligram of Satan”: A Multi-Perspective Qualitative Exploration of Adjuvant Endocrine Therapy Use after Breast Cancer by Kirsti I. Toivonen, Devesh Oberoi, Kathryn King-Shier, Katherine-Ann L. Piedalue, Joshua A. Rash, Linda E. Carlson, Tavis S. Campbell

Subjects: Get full text

Use of Adjuvant Endocrine Therapy Among Post-Menopausal Breast Cancer Patients in Malaysia by Saiful Bahri A, Tuan Mahmood TM, Abdul-Aziz SA, Makmor-Bakry M, Mohamed Shah N

Subjects: “…adjuvant endocrine therapy…”
Get full text

Health belief about adjuvant endocrine therapy in premenopausal breast cancer survivors: a qualitative study by Xu L, Wang A

Subjects: Get full text

Does age affect outcome with breast cancer? by Emily B Jackson, Lovedeep Gondara, Caroline Speers, Rekha Diocee, Alan M Nichol, Caroline Lohrisch, Karen A Gelmon

Subjects: Get full text

Does patient health literacy impact adherence to adjuvant endocrine therapy in breast cancer patients? by Keim-Malpass J, Doede A, Showalter SL

Subjects: Get full text

Cross-cultural adaptation of the simple Chinese version of the medication adherence reasons scale in patients undergoing adjuvant endocrine therapy for breast cancer by Lei Xu, Ping Li, Yan Hu, Weijie Xing, Jiajia Qiu, Xiaoju Zhang, Lingying Jia, Feng Jing, Ye Liu, Lili Li, Chunyang Lu

Subjects: Get full text

A comparison of survival outcomes and side effects of toremifene or tamoxifen therapy in premenopausal estrogen and progesterone receptor positive breast cancer patients: a retrosp... by Gu Ran, Jia Weijuan, Zeng Yunjie, Rao Nanyan, Hu Yue, Li Shunrong, Wu Jiannan, Jin Liang, Chen Lijuan, Long Meijun, Chen Kai, Chen Lili, Xiao Qiaozhen, Wu Mei, Song Erwei, Su Fengxi

Subjects: Get full text

Prevalence and determinants of adherence to oral adjuvant endocrine therapy among breast cancer patients in Singapore by Eskinder Eshetu Ali, Ka Lok Cheung, Chee Ping Lee, Jo Lene Leow, Kevin Yi-Lwern Yap, Lita Chew

Subjects: Get full text

Understanding adjuvant endocrine therapy persistence in breast Cancer survivors by Leah K. Lambert, Lynda G. Balneaves, A. Fuchsia Howard, Stephen K. Chia, Carolyn C. Gotay

Subjects: “…Adjuvant endocrine therapy…”
Get full text

Healthcare Provider Perspectives on Adherence to Adjuvant Endocrine Therapy after Breast Cancer by Leah K. Lambert, Lynda G. Balneaves, A. Fuchsia Howard, Stephen L. K. Chia, Carolyn C. Gotay

Subjects: “…adjuvant endocrine therapy…”
Get full text

MODERN VIEWS ON THE ROLE OF OVARIAN SUPPRESSION IN THE TREATMENT OF PATIENTS WITH HORMONE-DEPENDENT BREAST CANCER: SABCS-2017 NEWS by A. A. Bozhok

Subjects: “…adjuvant endocrine therapy…”
Get full text

Hot flushes and sweating, sleep problems, joint and muscular discomfort, and physical and mental exhaustion in breast cancer survivors during the first 24 months of tamoxifen thera... by Sumi Sung, Yul Ha Min, Seul Ki Park, Sae Byul Lee

Subjects: “…adjuvant endocrine therapy…”
Get full text

Factors influencing 5-year persistence to adjuvant endocrine therapy in young women with breast cancer by Eleonora Pagan, Monica Ruggeri, Nadia Bianco, Eraldo Oreste Bucci, Rossella Graffeo, Markus Borner, Monica Giordano, Lorenzo Gianni, Manuela Rabaglio, Andrea Freschi, Elisabetta Cretella, Elena Seles, Alberto Farolfi, Edda Simoncini, Mariangela Ciccarese, Daniel Rauch, Adolfo Favaretto, Friedemann Honecker, Rossana Berardi, Alessandra Franzetti-Pellanda, Shari Gelber, Ann H. Partridge, Aron Goldhirsch, Vincenzo Bagnardi, Olivia Pagani, Karin Ribi

Subjects: Get full text

Persistence to extended adjuvant endocrine therapy following Breast Cancer Index (BCI) testing in women with early-stage hormone receptor-positive (HR +) breast cancer by Julia Foldi, Anastasia Tsagianni, Max Salganik, Catherine A. Schnabel, Adam Brufsky, G. J. van Londen, Lajos Pusztai, Tara Sanft

Subjects: Get full text

Development of an e-health app to support women prescribed adjuvant endocrine therapy after treatment for breast cancer by Brett J, Boulton M, Watson E

Subjects: “…Adjuvant Endocrine Therapy (AET)…”
Get full text

Fear of cancer recurrence in South Korean survivors of breast cancer who have received adjuvant endocrine therapy: a cross-sectional study by Seul Ki Park, Yul Ha Min

Subjects: Get full text

Adjuvant endocrine therapy after breast cancer: a qualitative study of factors associated with adherence by Brett J, Boulton M, Fenlon D, Hulbert-Williams NJ, Walter FM, Donnelly P, Lavery BA, Morgan A, Morris C, Watson EK

Subjects: “…Adherence to adjuvant endocrine therapy…”
Get full text